HOXB9 Gene - Homeobox B9

Key regulator of embryonic development and oncogenesis

Gene Information Card

Symbol HOXB9
Full Name Homeobox B9
Gene Type Protein-coding
Chromosomal Location 17q21.32
NCBI Gene ID 3219 ncbi.nlm.nih.gov/gene/3219
Ensembl ID ENSG00000109685
UniProt ID P17482
OMIM ID 142964
HGNC ID 5117
Aliases HOX-2.5, HOX2E, Hoxb-9

Description

HOXB9 (Homeobox B9) is a member of the HOX gene family, which encodes transcription factors critical for embryonic development, particularly in the patterning of the anterior-posterior axis. HOXB9 is located on chromosome 17q21.32 within the HOXB cluster. It plays roles in cell proliferation, differentiation, and migration. Aberrant expression of HOXB9 is implicated in several cancers, including breast, lung, and colorectal cancers, where it can promote tumor progression and metastasis.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Breast Cancer Overexpression of HOXB9 promotes epithelial-mesenchymal transition (EMT) and metastasis via Wnt/β-catenin signaling. PMID: 20628086
Non-Small Cell Lung Cancer HOXB9 upregulation correlates with poor prognosis and enhances cell invasion through TGF-β pathway activation. PMID: 25242046
Colorectal Cancer HOXB9 is frequently overexpressed and associated with tumor growth and metastasis via activation of the PI3K/AKT pathway. PMID: 27323851
Acute Myeloid Leukemia HOXB9 is part of a HOX gene expression signature linked to leukemogenesis and poor outcome. PMID: 15692071

Expression Profile

Tissue Expression
Tissue nTPM level
Lung 12.5 Medium
Breast 8.3 Low
Colon 6.7 Low
Prostate 5.1 Low
Ovary 4.9 Low
Cell Line Expression
Cell Line nTPM Notes
MCF7 (Breast Cancer) 15.2 Overexpressed compared to normal breast tissue
A549 (Lung Cancer) 18.7 High expression; associated with invasive phenotype
HCT116 (Colorectal Cancer) 10.5 Moderate expression
K562 (Leukemia) 3.4 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1A>G (p.Met1?) Missense <0.1% Potential loss of start codon; effect uncertain
c.100C>T (p.Arg34Trp) Missense <0.1% Rare variant; functional impact unknown
c.200G>A (p.Arg67Gln) Missense <0.1% Reported in COSMIC; no known pathogenicity
Mutation functional classification

Loss of Function (LOF)

No confirmed loss-of-function mutations reported in major databases.

Gain of Function (GOF)

Overexpression in cancer is considered a gain-of-function event, but no specific activating mutations are documented.

Dominant Negative (DN)

No dominant-negative mutations described.

Pathways

Wnt signaling pathway (KEGG: hsa04310)
TGF-beta signaling pathway (KEGG: hsa04350)
PI3K-Akt signaling pathway (KEGG: hsa04151)
HOX gene regulation in development (Reactome: R-HSA-5619507)

Protein Summary

The HOXB9 protein is a 251-amino acid homeodomain-containing transcription factor. It binds DNA via a helix-turn-helix motif and regulates target genes involved in development and cell fate. The protein is predominantly nuclear and is expressed during embryogenesis in the posterior neural tube, mesoderm, and limb buds. In adults, expression is low in most tissues but is reactivated in various cancers, where it drives EMT, invasion, and metastasis.

Related Products

Product name Cat.No. Species Gene ID
HOXB9 Knockout HEK293 Cell Line EDJ-KQ4915 Human 3219 Details Get a Quote
HOXB9 Knockout A-549 Cell Line EDJ-KQ27748 Human 3219 Details Get a Quote
HOXB9 Knockout HCT 116 Cell Line EDJ-KQ27749 Human 3219 Details Get a Quote
HOXB9 Knockout HeLa Cell Line EDJ-KQ27750 Human 3219 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: